搜索
搜索
News
資訊分類
/
/
Food and drug administration issues a public notice (draft of soliciting opinions) on adjusting the review and approval of drug clinical trials

Food and drug administration issues a public notice (draft of soliciting opinions) on adjusting the review and approval of drug clinical trials

  • 分類:Industry news
  • 作者:
  • 來源:
  • 發佈時間:2019-06-18 17:40
  • 訪問量:

【概要描述】 Food and drug administration issues a public notice (draft of soliciting opinions) on adjusting the review and approval of drug clinical trials

Food and drug administration issues a public notice (draft of soliciting opinions) on adjusting the review and approval of drug clinical trials

【概要描述】 Food and drug administration issues a public notice (draft of soliciting opinions) on adjusting the review and approval of drug clinical trials 

  • 分類:Industry news
  • 作者:
  • 來源:
  • 發佈時間:2019-06-18 17:40
  • 訪問量:
詳情
In order to implement the requirements of the general office of the CPC Central Committee and the general office of the State Council on deepening the reform of the review and approval system and encouraging the innovation of pharmaceutical devices, the food and drug administration has organized the drafting of the announcement on adjusting the review and approval of clinical trials of drugs (Draft for comments), and now it is seeking opinions and suggestions publicly.
Please reply by email before January 14, 2018.
In order to encourage innovation, accelerate the creation of new drugs and meet the public demand for drug use, according to the general office of the CPC Central Committee and the general office of the State Council's opinions on deepening the reform of the review and approval system and encouraging the innovation of drug devices (Ting Zi [2017] No. 42), optimize the review and approval of drug clinical trials, learn from international experience, and adjust the review and approval procedures and channels of clinical trials.

掃二維碼用手機看

Copyright 2019 ©chinazhenlei.cn All Rights Reserved       浙ICP备17005887号

power:300.cn

Copyright 2019 ©chinazhenlei.cn

浙ICP备10036259号

网站建设: 中企动力  台州